🇺🇸 FDA
Patent

US 11035859

Compositions and methods for detecting protease activity in biological systems

granted A61KA61K47/6849A61K47/6855

Quick answer

US patent 11035859 (Compositions and methods for detecting protease activity in biological systems) held by CytomX Therapeutics, Inc. expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CytomX Therapeutics, Inc.
Grant date
Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
37
CPC classes
A61K, A61K47/6849, A61K47/6855, A61K47/6889, A61K49/0021